Murakami M - Search Results

1

Tyrosine dephosphorylation of STAT3 in SARS coronavirus-infected Vero E6 cells.

Mizutani T, Fukushi S, Murakami M, Hirano T, Saijo M, Kurane I, Morikawa S. Mizutani T, et al. Among authors: murakami m. FEBS Lett. 2004 Nov 5;577(1-2):187-92. doi: 10.1016/j.febslet.2004.10.005. FEBS Lett. 2004. PMID: 15527783 Free PMC article.

2

IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages.

Yasukawa H, Ohishi M, Mori H, Murakami M, Chinen T, Aki D, Hanada T, Takeda K, Akira S, Hoshijima M, Hirano T, Chien KR, Yoshimura A. Yasukawa H, et al. Among authors: murakami m. Nat Immunol. 2003 Jun;4(6):551-6. doi: 10.1038/ni938. Epub 2003 May 18. Nat Immunol. 2003. PMID: 12754507

3

New IL-6 (gp130) family cytokine members, CLC/NNT1/BSF3 and IL-27.

Murakami M, Kamimura D, Hirano T. Murakami M, et al. Growth Factors. 2004 Jun;22(2):75-7. doi: 10.1080/08977190410001715181. Growth Factors. 2004. PMID: 15253382 Review. No abstract available.

4

IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.

Park SJ, Nakagawa T, Kitamura H, Atsumi T, Kamon H, Sawa S, Kamimura D, Ueda N, Iwakura Y, Ishihara K, Murakami M, Hirano T. Park SJ, et al. Among authors: murakami m. J Immunol. 2004 Sep 15;173(6):3844-54. doi: 10.4049/jimmunol.173.6.3844. J Immunol. 2004. PMID: 15356132

5

IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells.

Kitamura H, Kamon H, Sawa S, Park SJ, Katunuma N, Ishihara K, Murakami M, Hirano T. Kitamura H, et al. Among authors: murakami m. Immunity. 2005 Nov;23(5):491-502. doi: 10.1016/j.immuni.2005.09.010. Immunity. 2005. PMID: 16286017 Free article.

6

Grasp a pTyr-peptide by its SOCS.

Hirano T, Murakami M. Hirano T, et al. Among authors: murakami m. Dev Cell. 2006 May;10(5):542-4. doi: 10.1016/j.devcel.2006.04.011. Dev Cell. 2006. PMID: 16678769 Free article.

7

Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells.

Sawa S, Kamimura D, Jin GH, Morikawa H, Kamon H, Nishihara M, Ishihara K, Murakami M, Hirano T. Sawa S, et al. Among authors: murakami m. J Exp Med. 2006 Jun 12;203(6):1459-70. doi: 10.1084/jem.20052187. Epub 2006 May 22. J Exp Med. 2006. PMID: 16717113 Free PMC article.

8

IL-2 in vivo activities and antitumor efficacy enhanced by an anti-IL-2 mAb.

Kamimura D, Sawa Y, Sato M, Agung E, Hirano T, Murakami M. Kamimura D, et al. Among authors: murakami m. J Immunol. 2006 Jul 1;177(1):306-14. doi: 10.4049/jimmunol.177.1.306. J Immunol. 2006. PMID: 16785526

9

IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.

Nishihara M, Ogura H, Ueda N, Tsuruoka M, Kitabayashi C, Tsuji F, Aono H, Ishihara K, Huseby E, Betz UA, Murakami M, Hirano T. Nishihara M, et al. Among authors: murakami m. Int Immunol. 2007 Jun;19(6):695-702. doi: 10.1093/intimm/dxm045. Epub 2007 May 9. Int Immunol. 2007. PMID: 17493959

10

Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.

Jin GH, Hirano T, Murakami M. Jin GH, et al. Among authors: murakami m. Int Immunol. 2008 Jun;20(6):783-9. doi: 10.1093/intimm/dxn036. Epub 2008 Apr 30. Int Immunol. 2008. PMID: 18448458

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,819 results

Search Page

Filters